Company Filing History:
Years Active: 2013
Title: Helmut Schlemper: Innovator in Indolopyridine Derivatives
Introduction
Helmut Schlemper is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of pharmacology through his innovative processes and research. His work primarily focuses on the preparation of enantiomerically pure indolopyridines, which are of great interest in medicinal chemistry.
Latest Patents
One of Schlemper's key patents is titled "Process for preparing enantiomerically pure indolopyridines." This patent discloses a novel process for the preparation of pharmacologically interesting indolopyridine derivatives. These derivatives contain tetracyclic tetrahydro-11-carboline-hydantoines linked to a basic side chain and the corresponding salts. They can be utilized as Eg5 inhibitors, achieving very high overall chemical yield and enantiomeric purity. Schlemper holds 1 patent in this area.
Career Highlights
Helmut Schlemper is associated with 4SC AG, a company that focuses on the development of innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has allowed him to explore and develop new pharmaceutical compounds that have the potential to make a significant impact in the medical field.
Collaborations
Schlemper has collaborated with Bernd Mueller, a fellow researcher, to advance their work in the field of pharmacology. Their combined expertise has contributed to the successful development of new processes and compounds.
Conclusion
Helmut Schlemper's contributions to the field of pharmacology, particularly through his patent on indolopyridine derivatives, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options in the pharmaceutical industry.